Who owns TransMedics Group, Inc. (TMDX)? Elite investor 13F holders

2 tracked elite investors reported holding TransMedics Group, Inc as of 2026-09-30, including Oaktree Capital Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

2 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Health Care Equipment & Services

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawTRANSMEDICS GROUP INCSHARE2026-09-302026-11-16 00:00:000.00 USD0.000000PrincipalexitedOriginal filing
Oaktree Capital ManagementTRANSMEDICS GROUP INCSHARE2026-06-302026-08-14 00:00:003396978.00 USD3131000.000000PrincipalbuyOriginal filing
Ancora Advisors / Ancora HoldingsTRANSMEDICS GROUP INCSHARE2026-09-302026-11-17 00:00:0042476.00 USD509.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown